Eversept Partners, LP - Q1 2023 holdings

$1.43 Billion is the total value of Eversept Partners, LP's 62 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 50.0% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TR TRput$167,849,900410,000
+100.0%
11.70%
NTRA BuyNATERA INC$156,553,630
+45.1%
2,819,770
+5.0%
10.92%
+15.5%
QQQ NewINVESCO QQQ TRput$144,418,500450,000
+100.0%
10.07%
BuyGSK PLCsponsored adr$133,929,238
+8.2%
3,731,499
+6.9%
9.34%
-13.9%
HZNP SellHORIZON THERAPEUTICS PUB L$89,399,193
-26.2%
819,124
-23.0%
6.23%
-41.2%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored ads$54,821,962
+27.6%
6,194,572
+31.4%
3.82%
+1.6%
UTHR SellUNITED THERAPEUTICS CORP DEL$49,743,084
-23.2%
222,107
-4.6%
3.47%
-38.8%
SNDX BuySYNDAX PHARMACEUTICALS INC$46,655,284
+13.1%
2,209,057
+36.3%
3.25%
-9.9%
CYH BuyCOMMUNITY HEALTH SYS INC NEW$44,503,295
+414.6%
9,082,305
+353.7%
3.10%
+309.9%
BIIB BuyBIOGEN INC$42,753,785
+12.4%
153,774
+12.0%
2.98%
-10.5%
ILMN BuyILLUMINA INC$39,658,379
+40.0%
170,537
+21.8%
2.76%
+11.5%
BCRX BuyBIOCRYST PHARMACEUTICALS INC$37,702,838
+273.0%
4,520,724
+413.4%
2.63%
+197.1%
CTLT SellCATALENT INC$37,691,847
+21.1%
573,609
-17.1%
2.63%
-3.6%
DHR SellDANAHER CORPORATION$37,513,898
-13.1%
148,685
-8.5%
2.62%
-30.8%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$24,814,542
-0.4%
689,676
+23.4%
1.73%
-20.7%
BuyAMARIN CORP PLCspons adr new$21,919,136
+451.6%
14,612,757
+345.0%
1.53%
+339.1%
CNC BuyCENTENE CORP DEL$18,231,407
+3.6%
288,426
+34.4%
1.27%
-17.5%
NewAMEDISYS INC$16,494,544224,263
+100.0%
1.15%
ICLR BuyICON PLC$16,401,149
+26.6%
76,788
+15.1%
1.14%
+0.9%
AVTR BuyAVANTOR INC$15,170,360
+19.8%
717,614
+19.6%
1.06%
-4.5%
MCRB BuySERES THERAPEUTICS INC$14,382,891
+16.7%
2,536,665
+15.3%
1.00%
-7.0%
TECH BuyBIO-TECHNE CORP$13,996,611
+915.2%
188,659
+1034.1%
0.98%
+706.6%
VERA BuyVERA THERAPEUTICS INCcl a$13,878,985
+74.4%
1,788,529
+334.8%
0.97%
+38.9%
ITCI NewINTRA-CELLULAR THERAPIES INC$11,844,013218,726
+100.0%
0.83%
EHTH NewEHEALTH INC$11,552,8891,234,283
+100.0%
0.81%
GH BuyGUARDANT HEALTH INC$11,323,817
+184.9%
483,098
+230.6%
0.79%
+127.0%
PCVX BuyVAXCYTE INC$11,208,394
+31.0%
299,050
+67.6%
0.78%
+4.4%
HUM BuyHUMANA INC$11,069,712
+3.2%
22,762
+8.9%
0.77%
-17.8%
IONS BuyIONIS PHARMACEUTICALS INC$10,842,408
+19.1%
303,369
+25.9%
0.76%
-5.1%
SWAV NewSHOCKWAVE MED INC$10,316,12147,577
+100.0%
0.72%
SellELEVANCE HEALTH INC$9,478,983
-34.1%
20,615
-26.5%
0.66%
-47.5%
THC SellTENET HEALTHCARE CORP$8,431,223
-32.1%
141,892
-44.3%
0.59%
-46.0%
MODN BuyMODEL N INC$8,095,389
-8.4%
241,870
+11.0%
0.56%
-27.1%
HCA NewHCA HEALTHCARE INC$7,359,04527,909
+100.0%
0.51%
XENE SellXENON PHARMACEUTICALS INC$7,275,105
-33.1%
203,272
-26.3%
0.51%
-46.7%
AMRX BuyAMNEAL PHARMACEUTICALS INC$7,204,434
+335.7%
5,183,046
+523.7%
0.50%
+246.2%
XBI NewSPDR SER TRput$6,096,80080,000
+100.0%
0.42%
PNTG NewPENNANT GROUP INC$6,025,789421,974
+100.0%
0.42%
PBYI BuyPUMA BIOTECHNOLOGY INC$5,988,692
-6.1%
1,938,088
+28.5%
0.42%
-25.1%
TARO BuyTARO PHARMACEUTICAL INDS LTD$5,964,893
-8.9%
245,267
+8.8%
0.42%
-27.4%
ZLAB NewZAI LAB LTDadr$5,720,687171,999
+100.0%
0.40%
LQDA SellLIQUIDIA CORPORATION$5,005,645
-39.1%
724,406
-43.9%
0.35%
-51.5%
AMN NewAMN HEALTHCARE SVCS INCput$3,318,40040,000
+100.0%
0.23%
IQV BuyIQVIA HLDGS INC$2,867,198
+28.5%
14,416
+32.4%
0.20%
+2.6%
HSKA BuyHESKA CORP$2,578,047
+113.0%
26,409
+35.6%
0.18%
+69.8%
 BIOHAVEN LTD$2,535,228
-1.6%
185,5950.0%0.18%
-21.7%
MRUS SellMERUS N V$2,374,630
-16.8%
129,056
-30.1%
0.17%
-33.6%
MEDP NewMEDPACE HLDGS INC$2,194,16711,668
+100.0%
0.15%
BuyGOHEALTH INCcl a new$2,035,863
+285.6%
125,053
+147.5%
0.14%
+208.7%
XOMA BuyXOMA CORP DEL$1,898,845
+18.8%
89,950
+3.5%
0.13%
-5.7%
EOLS SellEVOLUS INC$1,874,321
-65.0%
221,551
-69.0%
0.13%
-72.1%
A BuyAGILENT TECHNOLOGIES INC$1,813,637
+1.9%
13,110
+10.4%
0.13%
-19.2%
GOSS BuyGOSSAMER BIO INC$1,703,602
+409.1%
1,352,065
+776.8%
0.12%
+310.3%
PKI BuyPERKINELMER INC$1,643,762
+4.9%
12,335
+10.4%
0.12%
-16.1%
PRTK NewPARATEK PHARMACEUTICALS INC$1,621,724638,474
+100.0%
0.11%
ARGX BuyARGENX SEsponsored adr$1,429,217
+8.5%
3,836
+10.4%
0.10%
-13.0%
AFMD BuyAFFIMED N V$1,404,549
+243.0%
1,883,784
+470.5%
0.10%
+172.2%
AVTE SellAEROVATE THERAPEUTICS INC$1,013,381
-62.1%
50,242
-44.9%
0.07%
-69.7%
RGEN SellREPLIGEN CORP$952,244
-90.1%
5,656
-90.1%
0.07%
-92.2%
 AADI BIOSCIENCE INC$737,886
-43.6%
101,9180.0%0.05%
-55.7%
NewNEWAMSTERDAM PHARMA COMPANYordinary shares$608,05145,856
+100.0%
0.04%
ACIU  AC IMMUNE SA$291,538
+14.7%
124,5890.0%0.02%
-9.1%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-31,172
-100.0%
-0.00%
CTLT ExitCATALENT INCcall$0-2,000
-100.0%
-0.01%
CSU ExitSONIDA SENIOR LIVING INC$0-11,791
-100.0%
-0.01%
ELDN ExitELEDON PHARMACEUTICALS INC$0-67,743
-100.0%
-0.01%
GLYC ExitGLYCOMIMETICS INC$0-100,579
-100.0%
-0.03%
FATE ExitFATE THERAPEUTICS INC$0-43,562
-100.0%
-0.04%
CYH ExitCOMMUNITY HEALTH SYS INC NEWcall$0-312,900
-100.0%
-0.12%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDcall$0-272,900
-100.0%
-0.22%
CABA ExitCABALETTA BIO INC$0-282,874
-100.0%
-0.23%
PLRX ExitPLIANT THERAPEUTICS INC$0-137,423
-100.0%
-0.23%
INCY ExitINCYTE CORP$0-63,996
-100.0%
-0.45%
MRK ExitMERCK & CO INCcall$0-48,700
-100.0%
-0.47%
XBI ExitSPDR SER TRcall$0-90,000
-100.0%
-0.65%
ISEE ExitIVERIC BIO INC$0-350,747
-100.0%
-0.66%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-154,796
-100.0%
-0.70%
ExitHALEON PLCspon ads$0-1,881,470
-100.0%
-1.32%
XBI ExitSPDR SER TRs&p biotech$0-216,087
-100.0%
-1.57%
NVST ExitENVISTA HOLDINGS CORPORATION$0-642,405
-100.0%
-1.89%
ExitGSK PLCcall$0-2,093,700
-100.0%
-6.44%
SNY ExitSANOFIsponsored adr$0-1,603,348
-100.0%
-6.80%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMARIN CORP PLC21Q3 202312.5%
DANAHER CORPORATION21Q3 20238.1%
AFFIMED N V20Q3 20230.9%
ARGENX SE19Q3 20232.0%
GSK PLC18Q2 202213.1%
ASCENDIS PHARMA A/S18Q1 20227.7%
SANOFI18Q4 20227.2%
ENSIGN GROUP INC18Q1 20228.6%
CENTENE CORP DEL18Q3 20231.5%
ZOGENIX INC17Q4 202112.4%

View Eversept Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Eversept Partners, LP Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cabaletta Bio, Inc.February 14, 2023282,8741.0%
Teligent, Inc.Sold outFebruary 16, 202100.0%
Teligent, Inc.February 14, 20204,501,7998.4%

View Eversept Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08

View Eversept Partners, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eversept Partners, LP's holdings